Galande S, Muniyappa K
Department of Biochemistry, Indian Institute of Science, Bangalore, India.
Biochim Biophys Acta. 1996 Jul 31;1308(1):58-66. doi: 10.1016/0167-4781(96)00070-x.
A number of studies in yeast have shown that DNA topoisomerase II is essential for chromosome condensation and disjunction during mitosis at the metaphase/anaphase transition and meiosis I. Accordingly, kinetic and mechanistic studies have implied a role for topoisomerase II in chromosome disjunction. As a step toward understanding the nature and role of topoisomerase II in a mammalian germline in vivo, we have purified topoisomerase II from rat testis to homogeneity and ascertained several of its catalytic activities in conjunction with that of the purified enzyme from liver. The purified enzymes appeared to be monomers under denaturing conditions; however, they differed in their relative molecular mass. Topoisomerase II from testis and liver have apparent molecular masses of 150 +/- 10 kDa and 160 +/- 10 kDa, respectively. The native molecular mass of testis topoisomerase II as assayed by immunoblot analysis of cell-free extracts, prepared in the presence of SDS and a number of protease inhibitors, corroborated with the size of the purified enzyme. Both enzymes are able to promote decatenation and relax supercoiled DNA substrates in an ATP and Mg(2+)-dependent manner. However, quantitative comparison of catalytic properties of topoisomerase II from testis with that of the enzyme from liver displayed significant differences in their efficiencies. Optimal pH values for testis enzyme are 6.5 to 8.5 while they are 6 to 7.5 for the liver enzyme. Intriguingly, the relaxation activity of liver topoisomerase II was inhibited by potassium glutamate at 1 M, whereas testis enzyme required about half its concentration. These findings argue that topoisomerase II from rat testis is structurally distinct from that of its somatic form and the functional differences between the two enzymes parallels with the physiological environment that is unique to these two tissues.
多项在酵母中的研究表明,DNA拓扑异构酶II对于有丝分裂中期/后期转换以及减数分裂I期间的染色体凝聚和解离至关重要。相应地,动力学和机制研究暗示拓扑异构酶II在染色体解离中发挥作用。作为理解拓扑异构酶II在哺乳动物体内生殖系中的性质和作用的第一步,我们已将大鼠睾丸中的拓扑异构酶II纯化至同质,并结合从肝脏中纯化的酶确定了其几种催化活性。在变性条件下,纯化的酶似乎为单体;然而,它们的相对分子质量不同。睾丸和肝脏中的拓扑异构酶II的表观分子质量分别为150±10 kDa和160±10 kDa。通过在SDS和多种蛋白酶抑制剂存在下制备的无细胞提取物的免疫印迹分析测定,睾丸拓扑异构酶II的天然分子质量与纯化酶的大小相符。两种酶都能够以ATP和Mg(2+)依赖性方式促进连环DNA的解连环和松弛超螺旋DNA底物。然而,睾丸拓扑异构酶II与肝脏拓扑异构酶II的催化特性的定量比较显示它们在效率上存在显著差异。睾丸酶的最佳pH值为6.5至8.5,而肝脏酶的最佳pH值为6至7.5。有趣的是,1 M的谷氨酸钾可抑制肝脏拓扑异构酶II的松弛活性,而睾丸酶所需的浓度约为其一半。这些发现表明,大鼠睾丸中的拓扑异构酶II在结构上与其体细胞形式不同,并且这两种酶之间的功能差异与这两个组织特有的生理环境平行。